Results 311 to 320 of about 648,282 (342)

ACC inhibitor alone or co-administered with a DGAT2 inhibitor in patients with non-alcoholic fatty liver disease: two parallel, placebo-controlled, randomized phase 2a trials

Nature Medicine, 2021
Roberto A Calle, Neeta B Amin, Santos Carvajal-Gonzalez   +2 more
exaly  

Aramchol in patients with nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled phase 2b trial

Nature Medicine, 2021
, Anna L Fracanzani, Tali Gorfine
exaly  

Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer’s disease: a phase 1b, randomized, placebo-controlled trial

Nature Medicine, 2023
Catherine Mummery, Simon Ducharme, Juha O Rinne   +2 more
exaly  

THE PLACEBO RESPONSE

The Journal of Nervous and Mental Disease, 1963
S, GELFAND, L P, ULLMANN, L, KRASNER
openaire   +2 more sources

A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial

Nature Medicine, 2020
Raffael Nachbagauer, Jodi Feser, David I Bernstein   +2 more
exaly  

Safety and immunogenicity of the SARS-CoV-2 BNT162b1 mRNA vaccine in younger and older Chinese adults: a randomized, placebo-controlled, double-blind phase 1 study

Nature Medicine, 2021
Jingxin Li, Ai-Min Hui, Özlem Türeci
exaly  

Tropifexor for nonalcoholic steatohepatitis: an adaptive, randomized, placebo-controlled phase 2a/b trial

Nature Medicine, 2023
Arun J Sanyal, , Won Kim
exaly  

Dupilumab in patients with prurigo nodularis: two randomized, double-blind, placebo-controlled phase 3 trials

Nature Medicine, 2023
Sonja Ständer, John T O'malley
exaly  

Implications of Phytoestrogen Intake for Breast Cancer

Ca-A Cancer Journal for Clinicians, 2007
Christine Duffy
exaly  

Placebo responses in animals

Pain, 2012
openaire   +3 more sources